MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Firdapse$98,859K Agamree$36,713K Fycompa$13,771K Product Revenue Net$149,343K License And OtherRevenue$47K Total revenues$149,390K (5.63%↑ Y/Y)Operating income$73,232K (15.57%↑ Y/Y)Other income, net$10,997K (38.87%↑ Y/Y)Total operating costsand expenses$76,158K (-2.43%↓ Y/Y)Net income beforeincome taxes$84,229K (18.16%↑ Y/Y)Selling, general andadministrative$49,319K (5.13%↑ Y/Y)Cost of sales$14,475K (-19.18%↓ Y/Y)Amortization of intangibleassets$9,703K (3.83%↑ Y/Y)Research and development$2,661K (-31.54%↓ Y/Y)Net income$63,734K (12.33%↑ Y/Y)Unrealized gain (loss) onavailable-for-sale securities, net...$8K (109.88%↑ Y/Y)Income tax provision$20,495K (40.87%↑ Y/Y)Comprehensive income$63,742K (12.51%↑ Y/Y)
Income Statement

CATALYST PHARMACEUTICALS, INC. (CPRX)

CATALYST PHARMACEUTICALS, INC. (CPRX)

source: myfinsight.com